Time to progression was also longer for patients with an EGFR exon 19 deletion in serum (13 months) than in those with an L858R serum mutation.

• 疾病进展所需时间在那些血浆中EGFR外显子19删除患者中(13个月)要长于那些合并血浆中L858R变异的患者。